Arnogene: A Phosphocalcic Study in Dialysis

Completed

• Conditions: Dialysis
• Interventions: Genetic: blood sample

• Registration Number: NCT00858260
• Lead Sponsor: Hospices Civils de Lyon

Brief Summary

Searching for high morbi-mortality risk Klotho variants in dialysis patients

Detailed Description

Not available

Study Timeline

• Study Start: 2008-11
• Study Completion: 2009-02
• Study First Submitted: 2009-03-06
• Study First Submitted QC: 2009-03-06
• Study First Posted: 2009-03-09
• Status Verified: 2009-09
• Last Update Submitted: 2009-09-03
• Last Update Posted: 2009-09-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

• Every adult > 18 years old and treated by dialysis in centers located in the Rhone Alpes area in France.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
hemodialysis patients	blood sample	Adult patients undergoing maintenance dialysis since at leat three months

Primary Outcome Measures

Name	Time	Method
Assessing morbi-mortality based on Klotho variants

Secondary Outcome Measures

Name	Time	Method
Survival and serum phosphocalcic parameters

Trial Locations

Locations (1)

Hôpital Edouard Herriot; 🇫🇷 Lyon, France